Skip to content

Cytek Biosciences, Inc.

CTKB· NasdaqCore metricsCIK 1831915

Laboratory analytical instruments24 peers

Last sale
Nov 5, 2026 · -8.50%
Market cap
$703.62M
130.78M shares
Filings
466
$53.23M
Q3 2026+0.5% FY25 yoy
-$6.10M
Q3 2026N/M FY25 yoy
-$8.42M
Q3 2026N/M FY25 yoy
-$11.71M
Q3 2026derivedN/M FY25 yoy
-$0.05
Q3 2026N/M FY25 yoy
$66.81M
Q3 2026−8.0% FY25 yoy
$703.62M
—
3.4×
2.2×
-1.92%
—

Twelve months to Sep 30, 2026 · derived

Price

$5.38+36.90%+$1.45past year
Nov 5, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$201.49MFY 2025
$201.49M0FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$201,493,000reported
FY 20242024-12-31$200,453,000reported
FY 20232023-12-31$193,015,000reported
FY 20222022-12-31$164,036,000reported
FY 20212021-12-31$127,950,000reported
FY 20202020-12-31$92,839,000reported

Capital returns

Dividends and buybacks · FY2021 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$15.07M$15.07M—128.55M sh+0.4%—
FY2024—$21.61M$21.61M—128.10M sh−2.1%98.9%
FY2023—$44.15M$44.15M—130.82M sh−3.4%6974.9%
FY2022—$0.00$0.00—135.43M sh+1.0%—
FY2021—$0.00$0.00—134.08M sh+329.2%0.0%

Segments

Revenue by Geography, FY2022 to FY2025FY2022United States · FY2022 · $94.59MEMEA · FY2022 · $43.96MAPAC · FY2022 · $22.52MOther · FY2022 · $2.96MFY2023United States · FY2023 · $102.09MEMEA · FY2023 · $53.18MAPAC · FY2023 · $31.60MOther · FY2023 · $6.15MFY2024United States · FY2024 · $92.61MEMEA · FY2024 · $62.34MAPAC · FY2024 · $35.77MOther · FY2024 · $9.73MFY2025United States · FY2025 · $95.25MEMEA · FY2025 · $55.88MAPAC · FY2025 · $41.08MChina · FY2025 · $20.50MOther · FY2025 · $9.28M
LineFY2025ShareChange
United States$95.25M47%+2.9%
EMEA$55.88M28%−10.4%
APAC$41.08M20%+14.8%
China$20.50M10%—
Other$9.28M4.6%−4.6%
Total$201.49M

From the 10-K filed Feb 26, 2026CTKB

Laboratory analytical instruments

Cytek Biosciences, Inc. is the 10th largest of the 25 covered companies the SEC files under this code, by revenue. SIC 3826

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Cytek Biosciences, Inc. · CIK 1831915 · Engraved from SEC EDGAR